- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT01526759
Fiber Longer Term Study on Energy Intake (FLiTS)
The Effect of 2 Weeks of Supplementation of a High-gelling, High-viscous Dietary Fibre on Energy Intake
Dietary fibre seems to have a relevant role in body weight management. In an acute study the investigators found that high viscous-high gelling pectin increased feelings of satiety. The objective of this study is to study the effects of 2 weeks of supplementation of high gelling-high viscous fibre or a high gelling-high viscous non-fibre control on energy intake.
The investigators do this by measuring the difference in ad libitum energy intake after 15 days of pectin or 15 days of control supplements. The investigators will further measure differences in 24h feelings of satiety, fasting blood glucose and insulin, fermentation and composition of microbiota.
Visão geral do estudo
Status
Condições
Intervenção / Tratamento
Tipo de estudo
Inscrição (Real)
Estágio
- Não aplicável
Contactos e Locais
Locais de estudo
-
-
-
Wageningen, Holanda, 7002HD
- Wageningen University
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria:
- Age: 18-30 year
- BMI: 18.5-25 kg/m2
- Healthy: as judged by the participant
- H2 producer
Exclusion Criteria:
- Weight loss or weight gain of more than 5 kg during the last 2 months
- Using an energy restricted diet during the last 2 months
- Lack of appetite for any reason
- Restrained eater
- Smoking
- Heavy alcohol use: >5 drinks/day
- Reported stomach or bowel diseases or disorders (e.g. irritable bowel syndrome)
- Reported diabetes
- Reported thyroid disease or any other endocrine disorder
- Using medication other than birth control, paracetamol, aspirin, hey fever and asthma
- Antibiotic use <2 months before the study
- Reported intolerance, allergy, or not liking of the research foods
- Vegetarian
- Current dietary fibre supplementation
- Fasting glucose levels >5.8 mmol/l
- Experienced any problems with drawing blood in the past
- Thesis students or employees of the division of Human Nutrition
- Volunteers who participated in the ProVe study
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Ciência básica
- Alocação: Randomizado
- Modelo Intervencional: Atribuição cruzada
- Mascaramento: Quadruplicar
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
---|---|
Experimental: pectin
10 gram high gelling-high viscous fiber, added to a drink
|
15 days 1 daily consumption of a drink with 10g pectin added
|
Comparador de Placebo: control
10g gelatin, added to a drink
|
15 days 1 daily consumption of a drink with 10g gelatin added
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
---|---|---|
Energy intake
Prazo: change from placebo after 2 weeks
|
after 14 days of both intervention and placebo supplements ad libitum energy intake is measured for 3 days in a row.
The change in energy intake will be calculated.
|
change from placebo after 2 weeks
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
---|---|---|
satiety
Prazo: change from placebo after 1 day and 15 days
|
at day 1 and after 15 days of both supplement and placebo intake satiety is measured hourly over 1 day at waking hours.
The change in satiety will be calculated.
|
change from placebo after 1 day and 15 days
|
fasting glucose
Prazo: change from placebo after day 0, 1 and 15
|
at day 0, 1 and day 15 of supplementation period fasting glucose is measured
|
change from placebo after day 0, 1 and 15
|
fasting insulin
Prazo: change from placebo after day 0, 1 and 15
|
at day 0, 1 and day 15 of supplementation period fasting insulin is measured
|
change from placebo after day 0, 1 and 15
|
fasting leptin
Prazo: change from placebo after day 0, 1 and 15
|
at day 0, 1 and day 15 of supplementation period fasting leptin is measured
|
change from placebo after day 0, 1 and 15
|
hydrogen in breath
Prazo: change from placebo after day 2 and 15
|
at day 2 and at day 15 hydrogen is measured hourly over 1 day at waking hours
|
change from placebo after day 2 and 15
|
energy intake
Prazo: change from placebo after day 0 and 1
|
before supplement intake and after 1 day of supplement 1-day ad libitum energy intake is measured.
The change in energy intake will be calculated.
|
change from placebo after day 0 and 1
|
body weight
Prazo: change from placebo after day 0,1,2,14,15, 16 and 17
|
Each day the subject reports to the research center, body weight is measured.
The change in body weight compared to placebo will be calculated.
|
change from placebo after day 0,1,2,14,15, 16 and 17
|
adverse events
Prazo: daily from day 0 to day 16
|
participants will be asked to register adverse events daily in a diary.
They are also asked to report ae's to the researchers.
number and type of AEs after fibre supplements will be compared to number and type of AEs after placebo supplements
|
daily from day 0 to day 16
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Edith Feskens, Prof, Wageningen University
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo
Conclusão Primária (Real)
Conclusão do estudo (Real)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Estimativa)
Atualizações de registro de estudo
Última Atualização Postada (Estimativa)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Outros números de identificação do estudo
- NL38515.081.11
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .
Ensaios clínicos em LM pectin (10%)
-
Kangbuk Samsung HospitalConcluídoMiomaRepublica da Coréia
-
LaNova Medicines Development Co., Ltd.Shanghai Zhongshan Hospital; First Affiliated Hospital of Zhejiang University; Sir Run Run Shaw Hospital e outros colaboradoresRescindido
-
LaNova Medicines Zhejiang Co., Ltd.Ativo, não recrutando
-
LaNova Medicines LimitedRecrutamento
-
LaNova Australia Pty LimitedRescindidoTumor Sólido AvançadoAustrália
-
LaNova Medicines LimitedRecrutamentoTumor Sólido AvançadoChina
-
LaNova Medicines LimitedRescindido
-
Ganin Fertility CenterConcluídoInfertilidade | Desenvolvimento embrionárioEgito
-
Henan Cancer HospitalRecrutamentoNSCLC | Metástases cerebrais | Metástase LeptomeníngeaChina
-
LaNova Medicines LimitedRescindido